The LatAm-FINGERS trial found that older adults who followed a coached, structured lifestyle program improved their cognitive test scores 55% more than those who received only general health advice, according to results presented at the Alzheimer's Association International Conference (AAIC) 2026 in London on July 13, 2026, and published simultaneously in The Lancet. For someone with mild cognitive impairment or early memory concerns, the trial gives a concrete set of questions to bring to a clinician about which kind of lifestyle support actually moves cognitive outcomes, rather than just a general reminder to "eat better and exercise." The trial enrolled 1,065 adults ages 60 to 77 across 11 Latin American countries, all considered at increased risk of dementia, in a single-blind, multicenter randomized controlled trial. The sections below lay out what the study tested, who it applies to, and the specific questions its design suggests are worth raising at an appointment.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What did LatAm-FINGERS actually test?
- Does a diagnosis of mild cognitive impairment matter for these results?
- Why did the structured, coached program outperform general advice?
- How does this connect to the U.S. POINTER trial?
- What questions can a patient bring to a clinician?
What did LatAm-FINGERS actually test?
LatAm-FINGERS compared two approaches to lifestyle intervention head-to-head. One group received a structured, coached program combining supervised exercise, nutrition counseling, computerized cognitive training, cardiovascular risk monitoring, and structured social engagement. The other group received a self-guided "flexible lifestyle intervention," which amounted to general health advice without the same coaching or structure, according to the Alzheimer's Association press release.
Participants were followed for two years, and 82% completed that full follow-up period. No serious adverse events or deaths were attributed to either intervention, meaning both arms of the trial were considered safe to carry out at the scale tested, as reported by Healio. The trial was funded by the Alzheimer's Association and designed specifically to adapt the FINGERS lifestyle-intervention model to Latin American populations, rather than applying a program built for a different region unchanged, per Alzheimer-Europe.
Does a diagnosis of mild cognitive impairment matter for these results?
LatAm-FINGERS did not require participants to carry a formal diagnosis of mild cognitive impairment to enroll. Instead, eligibility was based on a CAIDE dementia-risk score above 6, combined with borderline-low scores on memory and cognition testing, such as an MMSE z-score between 0 and -1.5, according to the trial's ClinicalTrials.gov registry entry. People with dementia or major neurological disease were excluded.
This matters for how a reader should interpret the results. Someone who has been told they have mild cognitive impairment, or who has test scores and risk factors in a similar range, is reasonably close to the population this trial studied, even without an exact diagnostic match. A clinician can help translate a specific MCI diagnosis, or a risk profile like elevated blood pressure plus mild memory complaints, into where someone would have likely fallen within this trial's enrollment criteria.
Why did the structured, coached program outperform general advice?
The core finding was that structure and coaching, not the content of the advice itself, drove the difference in outcomes. Both groups were told to exercise, eat well, and stay socially engaged.
The group that improved more was the one that received supervised exercise sessions, individualized nutrition counseling, computerized cognitive training, ongoing monitoring of cardiovascular risk factors, and organized social activities, rather than being left to interpret and apply general guidance alone, per Healio's coverage. The composite improvement in global cognition was 55% greater in the structured group, with additional gains specifically in memory, executive function, and processing speed. That breakdown gives a reader a way to ask about which cognitive domains matter most for their own concerns, since memory complaints, difficulty planning or organizing tasks, and slowed thinking are often reported separately rather than as one combined problem.
How does this connect to the U.S. POINTER trial?
Organizers of LatAm-FINGERS describe the results as reinforcing the earlier U.S. POINTER trial, which found the same basic pattern: a structured, coached multidomain lifestyle program outperformed self-guided advice for cognitive outcomes, according to the AAIC 2026 press release.
Two independently run trials, in different populations, arriving at the same conclusion gives that conclusion more weight than either trial would carry alone. For a reader, this cross-trial agreement is a practical talking point. It suggests the benefit of coaching and structure over general advice is not specific to one country's healthcare system or one study's design, which is relevant when asking a clinician whether a similar structured approach is available or appropriate locally.
What questions can a patient bring to a clinician?
Because the measured benefit scaled with structure and coaching rather than with the advice itself, a patient with cognitive concerns or elevated dementia-risk factors has concrete, specific questions to raise rather than only asking for general lifestyle tips. The Healio report frames the practical takeaway as: find out whether a supervised, multidomain plan is a realistic option, not just whether lifestyle changes in general are worthwhile. Questions worth raising at an appointment include: A clinician can use answers to these questions to decide whether a coached, multidomain approach is accessible and appropriate, or whether a different combination of interventions fits a patient's specific risk factors and resources.
- Is a supervised exercise program available, as opposed to a general recommendation to "exercise more"?
- Can nutrition counseling be individualized, rather than following generic dietary advice?
- Does computerized cognitive training have a role for someone with my specific test results?
- Are my cardiovascular risk factors (blood pressure, cholesterol, blood sugar) being actively monitored and managed as part of a cognitive-health plan?
- Are there structured social engagement programs or resources that go beyond "stay social" as a suggestion?
You Might Also Like
- The AAIC 2026 Swedish Real-World Blood Test Study: Questions Younger-Onset Alzheimer’s Families Can Bring to a Clinician
- Blood Biomarker Counseling After the AAIC 2026 Findings: Questions Younger-Onset Alzheimer’s Families Can Bring to a Clinician
- The $781 Billion Dementia Economic Estimate in the 2026 NIA Report: Questions Spouses and Partners Can Ask Local Care Programs
